Your Trusted Source for Biopharma News

Editorial

View All
Your Trusted Source for Biopharma News
Editorial Building Resilience in Biopharma Amid Global Disruptions

Biopharma companies have always operated at the edge of uncertainty. Scientific discovery is inherently unpredictable, regulatory hurdles are steep, and supply chains span the globe. Yet the past…

BridgeBio's Breakthrough in Limb-Girdle Muscular Dystrophy Trials
EditorialBridgeBio's Breakthrough in Limb-Girdle Muscular Dystrophy Trials

The landscape of rare disease drug development is littered with clinical failures. For every

Price Pressures Are Here: How to Plan, Launch & LCM in the IRA Era
EditorialPrice Pressures Are Here: How to Plan, Launch & LCM in the IRA Era

Major policy changes are colliding with the complex economics of drug development. For B2B

The Commercial Case for Investing in Rare Disease Pipelines
EditorialThe Commercial Case for Investing in Rare Disease Pipelines

For decades, the commercial spotlight in biopharma has shone the brightest on high-prevalence

Nanotechnology: The Promise of Precision and Revolutionary Healthcare
EditorialNanotechnology: The Promise of Precision and Revolutionary Healthcare

Misdiagnosis is a problem facing medicine today. A significant reason for this challenge is that

View All

Research & Development

View All
View All

Tech & Innovation

View All
View All
How Is UNMC Revolutionizing Precision Oncology Care?
Tech & Innovation How Is UNMC Revolutionizing Precision Oncology Care?

In the heart of Omaha, Nebraska, the University of Nebraska Medical Center (UNMC) is quietly transforming the landscape of cancer treatment through its pioneering work in precision oncology, proving that geographic location is no barrier to innovation. Far from the bustling medical hubs of the East

Can AI Chatbots Safely Support Mental Health Needs?
Tech & InnovationCan AI Chatbots Safely Support Mental Health Needs?

In a world where mental health challenges are escalating, with millions struggling to access timely

Cellarity's AI Model Revolutionizes Drug-Induced Liver Injury Prediction
Tech & InnovationCellarity's AI Model Revolutionizes Drug-Induced Liver Injury Prediction

I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert whose extensive experience

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later